Genmab A/S (GNMSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,937 | 167,950 | 51,851 | 23,806 | -1,703 |
| Accounts receivable | N/A | -118,127 | N/A | N/A | N/A |
| Other Working Capital | 95,415 | -127,628 | -4,804 | -3,158 | -8,509 |
| Other Operating Activity | 9,473 | 126,504 | 13,852 | 9,929 | 8,934 |
| Operating Cash Flow | $107,826 | $48,699 | $60,899 | $30,576 | $-1,277 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -54,973 | -145,841 | -78,924 | -75,184 | -35,602 |
| PPE Investments | -553 | -1,821 | N/A | -1,069 | -607 |
| Purchase Sale Intangibles | N/A | -3,099 | -1,285 | N/A | N/A |
| Other Investing Activity | 0 | -3,099 | -1,285 | 0 | 0 |
| Investing Cash Flow | $-55,526 | $-150,761 | $-80,209 | $-76,253 | $-36,208 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 14,810 | 31,118 | 27,572 | 12,456 | 5,686 |
| Other Financing Activity | 0 | -17,567 | -17,733 | -18 | -9 |
| Financing Cash Flow | $14,810 | $13,551 | $9,840 | $12,438 | $5,677 |
| Exchange Rate Effect | -1,520 | 4,260 | -2,128 | -2,046 | -3,550 |
| Beginning Cash Position | 44,027 | 129,874 | 131,098 | 132,759 | 129,263 |
| End Cash Position | 109,617 | 45,624 | 119,500 | 97,474 | 93,904 |
| Net Cash Flow | $65,590 | $-84,251 | $-11,598 | $-35,284 | $-35,359 |
| Free Cash Flow | |||||
| Operating Cash Flow | 107,826 | 48,699 | 60,899 | 30,576 | -1,277 |
| Capital Expenditure | -553 | -1,821 | N/A | -1,069 | -607 |
| Free Cash Flow | 107,273 | 46,878 | 60,899 | 29,507 | -1,884 |